Meconium-induced release of cytokines is mediated by the TRL4/MD-2 complex in a CD14-dependent manner

Molecular Immunology

Volumn 47, Issue 6, 2010, Pages 1226-1234

  Salvesen, Bodil ^a,b   Stenvik, Jørgen ^c   Rossetti, Carlo ^d   Saugstad, Ola D ^b   Espevik, Terje ^c   Mollnes, Tom E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

CD14; CyP; Cytokines; Inflammation; Lipopolysaccharide; MD 2; Meconium; Toll like receptor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD14 ANTIGEN; CELL EXTRACT; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; LIPOPOLYSACCHARIDE; LUCIFERASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN ANTIBODY; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; EMBRYO; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; MECONIUM ASPIRATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD14; CELL LINE; CHEMOKINES; CYANOBACTERIA; CYTOKINES; HUMANS; INFANT, NEWBORN; INFLAMMATION; INFLAMMATION MEDIATORS; LYMPHOCYTE ANTIGEN 96; MECONIUM; NF-KAPPA B; POLYSACCHARIDES, BACTERIAL; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

CYANOBACTERIA;

EID: 76949084964     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.12.015     Document Type: Article

References (35)

1. Antonowicz I., and Shwachman H. Meconium in health and in disease. Adv. Pediatr. 26 (1979) 275-310
2. Castellheim A., Lindenskov P.H., Pharo A., Fung M., Saugstad O.D., and Mollnes T.E. Meconium is a potent activator of complement in human serum and in piglets. Pediatr. Res. 55 (2004) 310-318
3. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274 (1999) 10689-10692
4. Cleary G.M., and Wiswell T.E. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr. Clin. North Am. 45 (1998) 511-529
5. Dargaville P.A., and Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 117 (2006) 1712-1721
6. Fitzgerald K.A., Rowe D.C., and Golenbock D.T. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect. 6 (2004) 1361-1367
7. Gay N.J., and Gangloff M. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76 (2007) 141-165
8. Hellerud B.C., Stenvik J., Espevik T., Lambris J.D., Mollnes T.E., and Brandtzaeg P. Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation. Infect. Immun. 76 (2008) 4183-4189
9. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
10. Jemmett K., Macagno A., Molteni M., Heckels J.E., Rossetti C., and Christodoulides M. A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia. Infect. Immun. 76 (2008) 3156-3163
11. Jimenez E., Marin M.L., Martin R., Odriozola J.M., Olivares M., Xaus J., Fernandez L., and Rodriguez J.M. Is meconium from healthy newborns actually sterile?. Res. Microbiol. 159 (2008) 187-193
12. Kaczorowski D.J., Nakao A., Vallabhaneni R., Mollen K.P., Sugimoto R., Kohmoto J., Zuckerbraun B.S., McCurry K.R., and Billiar T.R. Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87 (2009) 1455-1463
13. Kawai T., and Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21 (2009) 317-337
14. Lee H.K., Dunzendorfer S., Soldau K., and Tobias P.S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24 (2006) 153-163
15. Levy R.M., Prince J.M., Yang R., Mollen K.P., Liao H., Watson G.A., Fink M.P., Vodovotz Y., and Billiar T.R. Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R970-R976
16. Macagno A., Molteni M., Rinaldi A., Bertoni F., Lanzavecchia A., Rossetti C., and Sallusto F. A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J. Exp. Med. 203 (2006) 1481-1492
17. Mackie R.I., Sghir A., and Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69 (1999) 1035S-1045S
18. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
19. Medzhitov R., and Janeway Jr. C. The Toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
20. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19 (2007) 3-10
21. Mollnes T.E., Brekke O.L., Fung M., Fure H., Christiansen D., Bergseth G., Videm V., Lappegard K.T., Kohl J., and Lambris J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100 (2002) 1869-1877
22. Mollnes T.E., Castellheim A., Lindenskov P.H., Salvesen B., and Saugstad O.D. The role of complement in meconium aspiration syndrome. J. Perinatol. 28 Suppl. 3 (2008) S116-S119
23. Muta T., and Takeshige K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of Toll-like receptor (TLR)2 as well as TLR4 reconstitution of. Eur. J. Biochem. 268 (2001) 4580-4589
24. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3 (2002) 667-672
25. Nilsen N.J., Deininger S., Nonstad U., Skjeldal F., Husebye H., Rodionov D., von A.S., Hartung T., Lien E., Bakke O., and Espevik T. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 84 (2008) 280-291
26. Okazaki K., Kondo M., Kato M., Kakinuma R., Nishida A., Noda M., Taniguchi K., and Kimura H. Serum cytokine and chemokine profiles in neonates with meconium aspiration syndrome. Pediatrics 121 (2008) e748-e753
27. Perera P.Y., Vogel S.N., Detore G.R., Haziot A., and Goyert S.M. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol. 158 (1997) 4422-4429
28. Romero R., Espinoza J., Goncalves L.F., Kusanovic J.P., Friel L.A., and Nien J.K. Inflammation in preterm and term labour and delivery. Semin. Fetal Neonatal Med. 11 (2006) 317-326
29. Salvesen B., Fung M., Saugstad O.D., and Mollnes T.E. Role of complement and CD14 in meconium-induced cytokine formation. Pediatrics 121 (2008) e496-e505
30. Salvesen B., Nielsen E.W., Harboe M., Saugstad O.D., and Mollnes T.E. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood. Mol. Immunol. 46 (2009) 688-694
31. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4 (2004) 469-478
32. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189 (1999) 1777-1782
33. Thorgersen E.B., Macagno A., Rossetti C., and Mollnes T.E. Cyanobacterial LPS antagonist (CyP)-A novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig. Mol. Immunol. 45 (2008) 3553-3557
34. Uthaisangsook S., Day N.K., Bahna S.L., Good R.A., and Haraguchi S. Innate immunity and its role against infections. Ann. Allergy Asthma Immunol. 88 (2002) 253-264
35. Viriyakosol S., Kirkland T., Soldau K., and Tobias P. MD-2 binds to bacterial lipopolysaccharide. J. Endotoxin. Res. 6 (2000) 489-491